Clinical Research Directory
Browse clinical research sites, groups, and studies.
PRP for Sexual Function
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
This randomized, single-blinded, sham-controlled trial evaluates whether a single injection of autologous platelet-rich plasma (PRP) into the distal anterior vaginal wall improves sexual function in women with sexual dysfunction. Sixty participants with a Female Sexual Function Index (FSFI) total score of 26.5 or lower are randomized 1:1 to PRP injection or sterile saline injection. Sexual function, sexual distress, global impression of change, and urinary incontinence symptoms are assessed at baseline, 6 weeks, and 6 months after injection.
Official title: Vaginal Injection of Platelet Rich Plasma for Sexual Dysfunction: A Randomized Control Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-08-27
Completion Date
2027-12
Last Updated
2026-11-06
Healthy Volunteers
No
Interventions
Autologous Platelet-Rich Plasma (PRP) Injection
Whole blood draw of 40 mL is processed by double-spin centrifugation; 4 cc PRP is injected with a 25-guage needle just deep to the epithelium of the distal anterior vaginal wall, about 3 cm from the urethral meatus, after topical lidocaine.
Sterile saline injection
4-5cc sterile saline injected at the same location, depth, and technique as the PRP arm, following a blood draw.
Locations (1)
The Mount Sinai Hospital
New York, New York, United States